Last update 21 Nov 2024
YTS-104
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms 合成性T细胞受体抗原受体 |
Target |
Mechanism LILRB4 inhibitors(Leukocyte immunoglobulin-like receptor subfamily B member 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  BriSTAR Immunotech LimitedStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Login to view timeline
Related
3
Clinical Trials associated with YTS-104An Exploratory Clinical Study on the Safety and Efficacy of YTS104 Cell Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
An Exploratory Clinical Study on the Safety and Efficacy of LILRB4 STAR-T Cells in the Treatment of Monocytic Leukemia
An Exploratory Clinical Study on the Safety and Efficacy of LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
100 Clinical Results associated with YTS-104
Login to view more data
100 Translational Medicine associated with YTS-104
Login to view more data
100 Patents (Medical) associated with YTS-104
Login to view more data
100 Deals associated with YTS-104
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Myeloma | Phase 1 | CN | BriSTAR Immunotech LimitedStartup | 15 Jun 2023 |
| Acute Myeloid Leukemia | Phase 1 | CN | BriSTAR Immunotech LimitedStartup | - |
| Chronic Myelomonocytic Leukemia | IND Application | CN | BriSTAR Immunotech LimitedStartup | 03 Nov 2023 |
| Refractory acute myeloid leukemia | IND Application | CN | BriSTAR Immunotech LimitedStartup | 03 Nov 2023 |
| Relapsing acute myeloid leukemia | IND Application | CN | BriSTAR Immunotech LimitedStartup | 03 Nov 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free